Stifel Nicolaus Has Lowered Expectations for Mettler-Toledo International (NYSE:MTD) Stock Price

Mettler-Toledo International (NYSE:MTDFree Report) had its target price reduced by Stifel Nicolaus from $1,550.00 to $1,450.00 in a research note released on Monday,Benzinga reports. They currently have a buy rating on the medical instruments supplier’s stock.

Several other brokerages have also recently issued reports on MTD. Robert W. Baird lowered their target price on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research note on Monday. Wells Fargo & Company dropped their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research note on Monday. JPMorgan Chase & Co. raised their target price on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research note on Monday, August 5th. Finally, Evercore ISI boosted their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $1,338.75.

View Our Latest Report on MTD

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,239.13 on Monday. The firm has a fifty day moving average of $1,388.91 and a 200 day moving average of $1,401.80. The firm has a market cap of $26.15 billion, a PE ratio of 33.41, a PEG ratio of 4.16 and a beta of 1.16. Mettler-Toledo International has a one year low of $1,039.01 and a one year high of $1,546.93.

Mettler-Toledo International (NYSE:MTDGet Free Report) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The firm had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. On average, equities analysts predict that Mettler-Toledo International will post 40.37 EPS for the current fiscal year.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares of the company’s stock, valued at $314,820. The trade was a 24.05 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.94% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Family Firm Inc. acquired a new position in shares of Mettler-Toledo International in the second quarter worth $25,000. Blue Trust Inc. raised its position in Mettler-Toledo International by 242.9% in the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 17 shares in the last quarter. Ashton Thomas Securities LLC purchased a new position in shares of Mettler-Toledo International in the 3rd quarter valued at about $37,000. Rothschild Investment LLC acquired a new position in shares of Mettler-Toledo International during the second quarter worth about $42,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in Mettler-Toledo International in the second quarter valued at approximately $42,000. Institutional investors and hedge funds own 95.07% of the company’s stock.

About Mettler-Toledo International

(Get Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Further Reading

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.